$IXHL Balance Sheet | Understand Stock

$IXHL

$2.58 -$0.13 (4.8%) Close

$IXHL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2026 As of Jun 30, 2026	Q3 FY2026 As of Mar 31, 2026	Q2 FY2026 As of Dec 31, 2025	Q1 FY2026 As of Sep 30, 2025	Q4 FY2025 As of Jun 30, 2025	Q3 FY2025 As of Mar 31, 2025	Q2 FY2025 As of Dec 31, 2024	Q1 FY2025 As of Sep 30, 2024	Q4 FY2024 As of Jun 30, 2024	Q3 FY2024 As of Mar 31, 2024	Q2 FY2024 As of Dec 31, 2023	Q4 FY2023 As of Jun 30, 2023	Q4 FY2022 As of Jun 30, 2022
Cash and cash equivalents
Trade and other receivables
Other assets
Total current assets
Property, plant and equipment
Right-of-use assets
Intangible assets
Total non-current assets
Trade and other payables
Lease liabilities
Total current liabilities
Total non-current liabilities
Net assets
Issued capital
Reserves
Accumulated losses
Current assets:
Cash and cash equivalents
Restricted cash
Prepaid expenses and other assets
Assets pledged as security for short-term debt
R&D tax incentive receivable
Total current assets
Property, plant and equipment, net
Investment in joint venture
Operating lease right-of-use assets, net
Total assets
Current liabilities:
Trade and other payables
Accrued expenses and other current liabilities
Short-term debt
Operating lease liabilities, current
Total current liabilities
Operating lease liabilities, non-current
Long-term debt
Warrant Liabilities
Convertible rights
Warrant liabilities
Total liabilities
Stockholders’ equity:
Common stock, $0.0001 par value – 800,000,000 shares authorized; 12,544,298 and 6,479,333 shares issued and outstanding at June 30, 2026 and 2025, respectively
Additional paid-in capital
Accumulated deficit
Foreign currency translation reserve
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments